[1] |
PINTO C, SOUSA DA, GHILAS V, et al. Acid sphingomyelinase deficiency: A clinical and immunological perspective[J]. Int J Mol Sci, 2021, 22( 23): 12870. DOI: 10.3390/ijms222312870.
|
[2] |
SCHUCHMAN EH, DESNICK RJ. Types A and B Niemann-Pick disease[J]. Mol Genet Metab, 2017, 120( 1-2): 27- 33. DOI: 10.1016/j.ymgme.2016.12.008.
|
[3] |
VÉLEZ PINOS PJ, SAAVEDRA PALACIOS MS, COLINA ARTEAGA PA, et al. Niemann-Pick disease: A case report and literature review[J]. Cureus, 2023, 15( 1): e33534. DOI: 10.7759/cureus.33534.
|
[4] |
COLOGNA SM, PATHMASIRI KC, PERGANDE MR, et al. Alterations in cholesterol and phosphoinositides levels in the intracellular cholesterol trafficking disorder NPC[J]. Adv Exp Med Biol, 2023, 1422: 143- 165. DOI: 10.1007/978-3-031-21547-6_5.
|
[5] |
ZHANG HW, WANG Y, GONG ZW, et al. Identification of a distinct mutation spectrum in the SMPD1 gene of Chinese patients with acid sphingomyelinase-deficient Niemann-Pick disease[J]. Orphanet J Rare Dis, 2013, 8: 15. DOI: 10.1186/1750-1172-8-15.
|
[6] |
LAN MY, LIN SJ, CHEN YF, et al. A novel missense mutation of the SMPD1 gene in a Taiwanese patient with type B Niemann-Pick disease[J]. Ann Hematol, 2009, 88( 7): 695- 697. DOI: 10.1007/s00277-008-0648-8.
|
[7] |
CHEEMA HA, RASOOL IG, ANJUM MN, et al. Mutational spectrum of SMPD1 gene in Pakistani Niemann-Pick disease patients[J]. Pak J Med Sci, 2020, 36( 3): 479- 484. DOI: 10.12669/pjms.36.3.467.
|
[8] |
WASSERSTEIN MP, DESNICK RJ, SCHUCHMAN EH, et al. The natural history of type B Niemann-Pick disease: Results from a 10-year longitudinal study[J]. Pediatrics, 2004, 114( 6): e672- e677. DOI: 10.1542/peds.2004-0887.
|
[9] |
LIPIŃSKI P, KUCHAR L, ZAKHAROVA EY, et al. Chronic visceral acid sphingomyelinase deficiency(Niemann-Pick disease type B) in 16 Polish patients: Long-term follow-up[J]. Orphanet J Rare Dis, 2019, 14( 1): 55. DOI: 10.1186/s13023-019-1029-1.
|
[10] |
MCGOVERN MM, POHL-WORGALL T, DECKELBAUM RJ, et al. Lipid abnormalities in children with types A and B Niemann Pick disease[J]. J Pediatr, 2004, 145( 1): 77- 81. DOI: 10.1016/j.jpeds.2004.02.048.
|
[11] |
CASSIMAN D, PACKMAN S, BEMBI B, et al. Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency(Niemann-Pick disease type B and B variant): Literature review and report of new cases[J]. Mol Genet Metab, 2016, 118( 3): 206- 213. DOI: 10.1016/j.ymgme.2016.05.001.
|
[12] |
LAN MY, KANG TW, LAN SC, et al. Spontaneous splenic rupture as the first clinical manifestation of Niemann-Pick disease type B: A case report and review of the literature[J]. J Clin Lipidol, 2022, 16( 4): 434- 437. DOI: 10.1016/j.jacl.2022.06.002.
|
[13] |
MCGOVERN MM, WASSERSTEIN MP, GIUGLIANI R, et al. A prospective, cross-sectional survey study of the natural history of Niemann-Pick disease type B[J]. Pediatrics, 2008, 122( 2): e341- e349. DOI: 10.1542/peds.2007-3016.
|
[14] |
ADIN ME, ONDER H, ALABALıK U. Echogenic splenic lesions in a child with type B Niemann-Pick disease[J]. J Clin Ultrasound, 2013, 41( Suppl 1): 32- 34. DOI: 10.1002/jcu.22009.
|
[15] |
THURBERG BL, WASSERSTEIN MP, SCHIANO T, et al. Liver and skin histopathology in adults with acid sphingomyelinase deficiency(Niemann-Pick disease type B)[J]. Am J Surg Pathol, 2012, 36( 8): 1234- 1246. DOI: 10.1097/PAS.0b013e31825793ff.
|
[16] |
MOLES A, TARRATS N, FERNÁNDEZ-CHECA JC, et al. Cathepsin B overexpression due to acid sphingomyelinase ablation promotes liver fibrosis in Niemann-Pick disease[J]. J Biol Chem, 2012, 287( 2): 1178- 1188. DOI: 10.1074/jbc.M111.272393.
|
[17] |
WANG RS, QIN ZY, HUANG L, et al. SMPD1 expression profile and mutation landscape help decipher genotype-phenotype association and precision diagnosis for acid sphingomyelinase deficiency[J]. Hereditas, 2023, 160( 1): 11. DOI: 10.1186/s41065-023-00272-1.
|
[18] |
PATTERSON MC, DI BISCEGLIE AM, HIGGINS JJ, et al. The effect of cholesterol-lowering agents on hepatic and plasma cholesterol in Niemann-Pick disease type C[J]. Neurology, 1993, 43( 1): 61- 64. DOI: 10.1212/wnl.43.1_part_1.61.
|
[19] |
WASSERSTEIN MP, DIAZ GA, LACHMANN RH, et al. Olipudase Alfa for treatment of acid sphingomyelinase deficiency(ASMD): Safety and efficacy in adults treated for 30 months[J]. J Inherit Metab Dis, 2018, 41( 5): 829- 838. DOI: 10.1007/s10545-017-0123-6.
|
[20] |
MIRANDA SR, ERLICH S, FRIEDRICH VL Jr, et al. Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann-Pick disease[J]. Gene Ther, 2000, 7( 20): 1768- 1776. DOI: 10.1038/sj.gt.3301300.
|
[21] |
LIU Y, LUO Y, XIA L, et al. The effects of liver transplantation in children with niemann-pick disease type B[J]. Liver Transpl, 2019, 25( 8): 1233- 1240. DOI: 10.1002/lt.25457.
|
[22] |
GASPERINI S, D’ANTIGA L. Liver transplantation for lysosomal storage disorders: A novel option to pick[J]. Liver Transpl, 2019, 25( 8): 1140- 1141. DOI: 10.1002/lt.25578.
|
[23] |
GEBERHIWOT T, WASSERSTEIN M, WANNINAYAKE S, et al. Consensus clinical management guidelines for acid sphingomyelinase deficiency(Niemann-Pick disease types A, B and A/B)[J]. Orphanet J Rare Dis, 2023, 18( 1): 85. DOI: 10.1186/s13023-023-02686-6.
|